PFIZER INC Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
PFIZER INC (PFE) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $1.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2019-02-28
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2018-12-31 was $0.00.
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2018-09-30 was $2.00M, a 83.33% decline year-over-year.
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2018-07-01 was $2.00M.
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2018-04-01 was -$3.00M.
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2018 was $1.00M.
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2017 was -$55.00M.
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2016 was -$1.71B.
- PFIZER INC disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2015 was $0.00.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.00M derived: sum of 2 quarters · filed 2019-02-28 | $4.00M derived: sum of 3 quarters · filed 2019-02-28 | $1.00M 10-K · filed 2019-02-28 |
| 2018-09-30 | $2.00M 10-Q · filed 2018-11-08 | $4.00M derived: sum of 2 quarters · filed 2018-11-08 | $1.00M 10-Q · filed 2018-11-08 | -$2.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-07-01 | $2.00M 10-Q · filed 2018-08-09 | -$1.00M 10-Q · filed 2018-08-09 | -$4.00M derived: sum of 3 quarters · filed 2019-02-28 | $8.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-04-01 | -$3.00M 10-Q · filed 2018-05-10 | -$6.00M derived: sum of 2 quarters · filed 2019-02-28 | $6.00M derived: sum of 3 quarters · filed 2019-02-28 | -$22.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $9.00M derived: sum of 2 quarters · filed 2019-02-28 | -$19.00M derived: sum of 3 quarters · filed 2019-02-28 | -$55.00M 10-K · filed 2019-02-28 |
| 2017-10-01 | $12.00M 10-Q · filed 2018-11-08 | -$16.00M derived: sum of 2 quarters · filed 2018-11-08 | -$52.00M 10-Q · filed 2018-11-08 | -$343.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-07-02 | -$28.00M 10-Q · filed 2018-08-09 | -$64.00M 10-Q · filed 2018-08-09 | -$355.00M derived: sum of 3 quarters · filed 2019-02-28 | -$1.78B derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-04-02 | -$37.00M 10-Q · filed 2018-05-10 | -$327.00M derived: sum of 2 quarters · filed 2019-02-28 | -$1.75B derived: sum of 3 quarters · filed 2019-02-28 | -$1.75B derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$290.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$1.71B derived: sum of 2 quarters · filed 2019-02-28 | -$1.71B derived: sum of 3 quarters · filed 2019-02-28 | -$1.71B 10-K · filed 2019-02-28 |
| 2016-10-02 | -$1.42B 10-Q · filed 2017-11-09 | -$1.42B derived: sum of 2 quarters · filed 2017-11-09 | -$1.42B 10-Q · filed 2017-11-09 | |
| 2016-07-03 | $0.00 10-Q · filed 2017-08-10 | $0.00 10-Q · filed 2017-08-10 | ||
| 2016-04-03 | $0.00 10-Q · filed 2017-05-11 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-22 | |||
| 2011-12-31 | -$15.00M 10-K · filed 2012-02-28 | |||
| 2010-12-31 | $155.00M 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $670.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |